Femoral Stems Market by Type and Geography - Forecast and Analysis 2022-2026

The femoral stem market share is expected to increase by USD 255.58 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 5.26%.

This femoral stem market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers femoral stem market segmentation by type (cementless femoral stems and cemented femoral stems) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The femoral stems market report also offers information on several market vendors, including Akcome Medical Holdings Co. Ltd., Altimed JSC, Amplitude SAS, B. Braun SE, Beijing Chunlizhengda Medical Instruments Co. Ltd., BEZNOSKA Sro, Biotechni SAS, Corentec Co. Ltd., EVOLUTIS SAS, Exactech Inc., GROUP FH ORTHO, Gruppo Bioimpianti Srl, IMECO SA, ImplanTec GmbH, Johnson and Johnson, Lepine Group, Limacorporate Spa, Medacta Group SA, Meril Life Sciences Pvt. Ltd., PETER BREHM GmbH, Smith and Nephew plc, Stryker Corp., X.NOV, and Zimmer Biomet Holdings Inc. among others.

What will the Femoral Stems Market Size be During the Forecast Period?

Download Report Sample to Unlock the Femoral Stems Market Size for the Forecast Period and Other Important Statistics

 

Femoral Stems Market: Key Drivers, Trends, and Challenges

The advances in femoral stems is notably driving the femoral stem market growth, although factors such as the shortage of skilled orthopedic surgeons may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the femoral stem industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Femoral Stems Market Driver

Advances in femoral stems is one of the major drivers impacting the femoral stem market growth. Tapered titanium stems offer various advantages such as ease of insertion; less stress shielding of the proximal bone; less thigh pain, especially in larger-sized tapered titanium stems; and versatility to accommodate various types of patient types, including those with obesity, inflammatory arthritis, or osteopenic bone. These items are also associated with fewer complications in insertion and extraction. The advent of porous-coated femoral stems has allowed for an increased surface area contact between the bone and the component to enable more bony ingrowth onto the component. The use of computer-aided design and modular components helps assure a secure fit of implants. Furthermore, new surgical techniques allow hip replacement surgeries to be performed through small incisions, which lead to short hospital stays, reduced blood loss, less pain, and a quick return to normal work. Such advances are increasing the adoption of femoral stems, which, in turn, is driving market growth.

Key Femoral Stems Market Trend

An increasing number of femoral stem replacement procedures is one of the major trends influencing the femoral stem market growth. The number of femoral stem replacement procedures being performed has been steadily increasing. This is mainly attributed to the rising demand for total revision hip replacement surgeries. In 2016, nearly seven of every 100 hip replacement surgeries performed in the US were revision hip replacement surgeries. Also, the annual total utilization of revision THR is expected to increase to approximately 147,000 by 2035. The improved life expectancy and the need for performing individual activities are propelling the demand for femoral stem revision procedures. Revision hip replacement surgeries involve the removal and replacement of one or more prosthesis components. A significant proportion of these cases require the replacement of femoral stems. Thus, there is an increase in demand for femoral stems, which, in turn, is expected to drive market growth during the forecast period.

Key Femoral Stems Market Challenge

The shortage of skilled orthopedic surgeons is one of the major challenges impeding the femoral stem market growth. Developed countries, such as the US, are expected to witness a shortage of skilled orthopedists in the coming years. The supply of orthopedic surgeons is expected to be significantly lower than the demand in the US by 2025. One of the major reasons for the shortage of orthopedic surgeons in the US is related to sub-specialization. Surgeons with an orthopedic subspecialty are reluctant to set up their practices in smaller cities as the patient population is insufficient to justify the high investments. Thus, the majority of skilled orthopedists are concentrated in bigger cities, whose practice is limited to a certain area. Furthermore, patients residing in smaller cities have limited access to skilled orthopedists. Furthermore, a significant proportion of orthopedic surgeons are currently nearing their retirement. Also, the declining reimbursement for several major orthopedic procedures, including hip and knee replacement

This femoral stems market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global femoral stem market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the femoral stem market during the forecast period.

Who are the Major Femoral Stems Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

• Akcome Medical Holdings Co. Ltd.
• Altimed JSC
• Amplitude SAS
• B. Braun SE
• Beijing Chunlizhengda Medical Instruments Co. Ltd.
• BEZNOSKA Sro
• Biotechni SAS
• Corentec Co. Ltd.
• EVOLUTIS SAS
• Exactech Inc.
• GROUP FH ORTHO
• Gruppo Bioimpianti Srl
• IMECO SA
• ImplanTec GmbH
• Johnson and Johnson
• Lepine Group
• Limacorporate Spa
• Medacta Group SA
• Meril Life Sciences Pvt. Ltd.
• PETER BREHM GmbH
• Smith and Nephew plc
• Stryker Corp.
• X.NOV
• Zimmer Biomet Holdings Inc.

 

This statistical study of the femoral stem market encompasses successful business strategies deployed by the key vendors. The femoral stems market is fragmented and the vendors are deploying growth strategies such as developing innovative technologies to compete in the market.

Product Insights and News

• ak-medical.net - The company offers femoral stems such as MR modular for bone splitting during implantation.

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The femoral stems market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Femoral Stems Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the femoral stems market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for the Femoral Stems Market?

For more insights on the market share of various regions Request PDF Sample now!

49% of the market’s growth will originate from North America during the forecast period. The US is the key market for the femoral stem market in North America. Market growth in this region will be faster than the growth of the market in other regions.

The increased adoption of advanced femoral stems will facilitate the femoral stems market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 in 2020 adversely affected all countries in the region, especially the US. It had a mixed impact on the regional market in 2020. Partial lockdowns in several countries, including Canada and Mexico, were implemented to control the spread of COVID-19 in 2020. Various non-urgent treatments such as hip replacements and clinical visits were wholly or partially restricted as per the COVID-19 guidelines. 

What are the Revenue-generating Type Segments in the Femoral Stems Market?

To gain further insights on the market contribution of various segments Request a PDF Sample

The femoral stem market share growth in the cementless femoral stems segment will be significant during the forecast period. Cementless femoral stems have a porous coating or a rough surface that allows new bone to grow on it (after it is inserted into its position inside the bone). It also fills the open spaces of the texture and forms a permanent bond between the bone and the implant. Cementless fixation is the gold standard for hip replacement surgeries, especially for young patients, because of its long-term results and clinical success. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the femoral stem market size and actionable market insights on the post-COVID-19 impact on each segment.

 

Femoral Stems Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 5.26%
Market growth 2022-2026	$ 255.58 million
Market structure	Fragmented
YoY growth (%)	4.19
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 49%
Key consumer countries	US, Germany, France, China, and Japan
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Akcome Medical Holdings Co. Ltd., Altimed JSC, Amplitude SAS, B. Braun SE, Beijing Chunlizhengda Medical Instruments Co. Ltd., BEZNOSKA Sro, Biotechni SAS, Corentec Co. Ltd., EVOLUTIS SAS, Exactech Inc., GROUP FH ORTHO, Gruppo Bioimpianti Srl, IMECO SA, ImplanTec GmbH, Johnson and Johnson, Lepine Group, Limacorporate Spa, Medacta Group SA, Meril Life Sciences Pvt. Ltd., PETER BREHM GmbH, Smith and Nephew plc, Stryker Corp., X.NOV, and Zimmer Biomet Holdings Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Femoral Stems Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive femoral stems market growth during the next five years
• Precise estimation of the femoral stems market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the femoral stems industry across North America, Europe, Asia, and the Rest of the World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of femoral stems market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch